Dr Kristin Schick Fonseca, OD - Medicare Optometrist in Southaven, MS

Dr Kristin Schick Fonseca, OD is a medicare enrolled "Optometrist" provider in Southaven, Mississippi. Her current practice location is 726 Goodman Rd E Ste B, Southaven, Mississippi. You can reach out to her office (for appointments etc.) via phone at (662) 349-1959.

Dr Kristin Schick Fonseca is licensed to practice in Mississippi (license number 987) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1477960763.

Contact Information

Dr Kristin Schick Fonseca, OD
726 Goodman Rd E Ste B,
Southaven, MS 38671-9530
(662) 349-1959
(662) 510-2391



Healthcare Provider's Profile

Full NameDr Kristin Schick Fonseca
GenderFemale
SpecialityOptometrist
Location726 Goodman Rd E Ste B, Southaven, Mississippi
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1477960763
  • Provider Enumeration Date: 07/17/2014
  • Last Update Date: 08/13/2019
  Medicare PECOS Information:
  • PECOS PAC ID: 5698004109
  • Enrollment ID: I20190909003683

Medical Identifiers

Medical identifiers for Dr Kristin Schick Fonseca such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1477960763NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist 3193 (Tennessee)Secondary
152W00000XOptometrist 987 (Mississippi)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Kristin Schick Fonseca allows following entities to bill medicare on her behalf.
Provider NameDesoto Eyecare Inc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1376576884
PECOS PAC ID: 1254232655
Enrollment ID: O20080721000259

News Archive

CytRx begins Phase 1b trial of aldoxorubicin plus gemcitabine in patients with metastatic solid tumors

CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced the initiation of enrollment in an open-label Phase 1b clinical trial designed to investigate the preliminary safety and activity of aldoxorubicin plus gemcitabine in subjects with metastatic solid tumors.

Immunologists discover risk factor responsible for infectious mononucleosis in young people

More than 90 percent of all adults are carriers of the oncogenic Epstein-Barr Virus. Primary infection with this herpes virus as a young child is generally not linked to any symptoms, and usually offers life-long protection from its cancer-causing effect. However, for people who do not become infected with the virus until adolescence, the infection often leads to infectious mononucleosis (commonly known as glandular fever). Our immune systems can generally fend off this disease after a period of between one and several months. However, there is an increased risk of developing Hodgkin lymphoma at a later stage, a cancerous tumor of the lymphatic system.

LivaNova's latest VNS Therapy earns CE Mark for expanded MRI labeling

LivaNova PLC , a market-leading medical technology company, today announced its latest VNS Therapy Systems ("VNS Therapy") received CE Mark for expanded MRI labeling. VNS Therapy is now the only implantable device indicated for epilepsy therapy that allows patients to have high-quality 1.5T and 3T MRI scans without the need for special equipment.

Roche and Genentech to discuss their radical collaborative business model at the Windhover Conference

Elsevier Business Intelligence and Windhover Conferences have announced a major addition to the lineup for their upcoming Therapeutic Area Partnerships event, Nov. 17-19 in Boston, MA. In Roche and Genentech: Understanding Their Collaborative Business Development Model, the two executives who designed and implemented the radical new collaborative business model will share exactly how they make this relationship work and the outlook for the business model in the future.

Loss of healthy bacteria may contribute to increasing rates of depression, say researchers

In an effort to pinpoint potential triggers leading to inflammatory responses that eventually contribute to depression, researchers are taking a close look at the immune system of people living in today's cleaner modern society.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Kristin Schick Fonseca is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Kristin Schick Fonseca, OD
726 Goodman Rd E Ste B,
Southaven, MS 38671-9530

Ph: (662) 349-1959
Dr Kristin Schick Fonseca, OD
726 Goodman Rd E Ste B,
Southaven, MS 38671-9530

Ph: (662) 349-1959

News Archive

CytRx begins Phase 1b trial of aldoxorubicin plus gemcitabine in patients with metastatic solid tumors

CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced the initiation of enrollment in an open-label Phase 1b clinical trial designed to investigate the preliminary safety and activity of aldoxorubicin plus gemcitabine in subjects with metastatic solid tumors.

Immunologists discover risk factor responsible for infectious mononucleosis in young people

More than 90 percent of all adults are carriers of the oncogenic Epstein-Barr Virus. Primary infection with this herpes virus as a young child is generally not linked to any symptoms, and usually offers life-long protection from its cancer-causing effect. However, for people who do not become infected with the virus until adolescence, the infection often leads to infectious mononucleosis (commonly known as glandular fever). Our immune systems can generally fend off this disease after a period of between one and several months. However, there is an increased risk of developing Hodgkin lymphoma at a later stage, a cancerous tumor of the lymphatic system.

LivaNova's latest VNS Therapy earns CE Mark for expanded MRI labeling

LivaNova PLC , a market-leading medical technology company, today announced its latest VNS Therapy Systems ("VNS Therapy") received CE Mark for expanded MRI labeling. VNS Therapy is now the only implantable device indicated for epilepsy therapy that allows patients to have high-quality 1.5T and 3T MRI scans without the need for special equipment.

Roche and Genentech to discuss their radical collaborative business model at the Windhover Conference

Elsevier Business Intelligence and Windhover Conferences have announced a major addition to the lineup for their upcoming Therapeutic Area Partnerships event, Nov. 17-19 in Boston, MA. In Roche and Genentech: Understanding Their Collaborative Business Development Model, the two executives who designed and implemented the radical new collaborative business model will share exactly how they make this relationship work and the outlook for the business model in the future.

Loss of healthy bacteria may contribute to increasing rates of depression, say researchers

In an effort to pinpoint potential triggers leading to inflammatory responses that eventually contribute to depression, researchers are taking a close look at the immune system of people living in today's cleaner modern society.

Read more News

› Verified 7 days ago


Optometrist in Southaven, MS

Dr. Heather Michelle Dowdy, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 6811 Southcrest Pkwy, Southaven, MS 38671
Phone: 662-349-1920    Fax: 662-349-1995
Obreineyecare
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 354 Stateline Rd W, Southaven, MS 38671
Phone: 662-647-8707    Fax: 662-647-8706
Parth Amin, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 940 Church Rd W Ste C, Southaven, MS 38671
Phone: 662-331-3937    
Alan Charles Smith, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 1228 Goodman Rd E Ste 1, Southaven, MS 38671
Phone: 662-349-8838    Fax: 662-349-8875
Dr. Taylor Nicole Keys, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 7900 Airways Blvd Bldg A1, Southaven, MS 38671
Phone: 901-228-0092    
Dr. Michael Edward Obrien, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 1890 Goodman Rd E, Suite 100, Southaven, MS 38671
Phone: 662-772-5882    Fax: 662-772-5808
Eyear Optical
Optometrist
Medicare: Medicare Enrolled
Practice Location: 3044 Goodman Rd E, Southaven, MS 38672
Phone: 662-349-1660    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.